Trump signed a nuclear deal with Saudi, then rewrote its terms on social media to include Israel

Trump said the new 30-year U.S.-Saudi civilian nuclear program would be contingent on Saudi joining the Abraham Accords, while also stating the deal bars uranium enrichment—though experts warn it may lack sufficient guardrails. The agreement will be submitted to Congress for review and notably excludes the IAEA “additional protocol,” raising monitoring/verification concerns, with early scrutiny building among lawmakers, Israeli officials, and nuclear experts. U.S. officials argue the setup steers procurement toward American firms, but the controversy and potential enrichment pathway after a joint U.S.-Saudi study keep political risk elevated for the program.

Analysis

This is less a near-term earnings event than a control-rights battle over who gets the long-duration procurement annuity. If Washington successfully ties the package to U.S. vendors and a no-enrichment framework, the economic upside accrues to the nuclear supply chain first, not to the headline country exposure: fuel-cycle names, engineering/services, and domestic fabrication capacity get the option value. If the political conditions slow the deal, the beneficiaries shift to non-U.S. competitors with more flexible export models, while U.S. firms lose exclusivity.

The market’s main mistake is likely to treat this as a binary geopolitical headline instead of a multi-stage approval process. Over the next 1-3 months, Congress and the Saudi response matter far more than the announcement itself; any lack of an additional protocol or ambiguity around enrichment raises the odds of delay, dilution, or a vendor switch. That argues for caution on broad nuclear beta until the legal text is public.

Contrarian view: the consensus is probably overrating the probability of a clean U.S. win and underrating the friction from Israeli redlines and Saudi bargaining leverage. If this stalls, the move reverses quickly because there is no immediate revenue to anchor a rerating. Over 6-18 months, the real tell is whether this becomes a U.S.-anchored fuel/services program or a generic Gulf sourcing project that leaks share to Korea/France/China.

Key Decisions for Investors

• No immediate directional trade; set an alert for the public 123 agreement text and congressional committee language. The thesis is invalidated if Congress adds little resistance and Saudi signs away enrichment rights quickly.
• If the final framework confirms U.S. vendor preference plus strict fuel-cycle controls, initiate a tactical long in LEU or URA on a 1-3 month horizon. Use the first post-confirmation pullback as entry; stop out if the deal slips into open-ended review.
• If enrichment remains unresolved or Congress signals procedural opposition, fade the nuclear-beta reaction with a short in URA against a smaller long in a quality utility/nuclear name. Target a 2-6 week mean reversion as the headline premium fades.
• Watch non-U.S. competitors like Korean and French nuclear exporters for relative strength if the U.S. package gets bogged down; that would confirm the market is pricing execution risk over geopolitics.